TABLE OF CONTENTS 
1.0 CHECKLIST FOR PATIENT ELIGIBILITY AND NECESSARY 
INFORMATION 1 
2.0 OBJECTIVES 2 
3.0 BACKGROUND AND RATIONALE 2 
4.0 DRANSDUCTION OF NEUROBLASTOMA CELLS 6 
5.0 PATIENT ELIGIBILITY 6 
6.0 TREATMENT PLAN 8 
7.0 PATIENT EVALUATION 9 
8.0 EVALUATION DURING STUDY 10 
9.0 CRITERIA OF RESPONSE AND STATISTICAL CONSIDERATIONS 11 
10.0 OFF-STUDY CRITERIA 13 
11.0 RECORDS TO BE KEPT 14 
12.0 REPORTING REQUIREMENTS 14 
13.0 OBTAINING INFORMED CONSENT 15 
14.0 REFERENCES 17 
15.0 SUMMARY STATEMENT 23 
APPENDIX A (Common Toxicity Criteria) 
Recombinant DNA Research, Volume 15 
[745] 
